Generic placeholder image

Current Diabetes Reviews

Editor-in-Chief

ISSN (Print): 1573-3998
ISSN (Online): 1875-6417

Research Article

Comparing Methods for Induction of Insulin Resistance in Mouse 3T3-L1 Cells

Author(s): Hend Al-Jaber, Shamma Al-Muraikhy, Aldana Jabr, Aisha Yousef, Najeha R. Anwardeen, Mohamed A. Elrayess* and Layla Al-Mansoori*

Volume 21, Issue 4, 2025

Published on: 09 January, 2024

Article ID: e090124225423 Pages: 12

DOI: 10.2174/0115733998263359231211044539

Price: $65

Abstract

Cell culture plays a crucial role in addressing fundamental research questions, particularly in studying insulin resistance (IR) mechanisms. Multiple in vitro models are utilized for this purpose, but their technical distinctions and relevance to in vivo conditions remain unclear. This study aims to assess the effectiveness of existing in vitro models in inducing IR and their ability to replicate in vivo IR conditions.

Background: Insulin resistance (IR) is a cellular condition linked to metabolic disorders. Despite the utility of cell culture in IR research, questions persist regarding the suitability of various models. This study seeks to evaluate these models' efficiency in inducing IR and their ability to mimic in vivo conditions. Insights gained from this research could enhance our understanding of model strengths and limitations, potentially advancing strategies to combat IR and related disorders.

Objective: 1- Investigate the technical differences between existing cell culture models used to study molecular mediators of insulin resistance (IR).

2- Compare the effectiveness of present in vitro models in inducing insulin resistance (IR).

3- Assess the relevance of the existing cell culture models in simulating the in vivo conditions and environment that provoke the induction of insulin resistance (IR).

Methods and Material: In vitro, eight sets of 3T3-L1 cells were cultured until they reached 90% confluence. Subsequently, adipogenic differentiation was induced using a differentiation cocktail (media). These cells were then divided into four groups, with four subjected to normal conditions and the other four to hypoxic conditions. Throughout the differentiation process, each cell group was exposed to specific factors known to induce insulin resistance (IR). These factors included 2.5 nM tumor necrosis factor-alpha (TNFα), 20 ng/ml interleukin-6 (IL-6), 10 micromole 4-hydroxynonenal (4HNE), and high insulin (HI) at a concentration of 100 nM. To assess cell proliferation, DAPI staining was employed, and the expression of genes associated with various metabolic pathways affected by insulin resistance was investigated using Real-Time PCR. Additionally, insulin signaling was examined using the Bio-plex Pro cell signaling Akt panel.

Results: We induced insulin resistance in 3T3-L1 cells using IL-6, TNFα, 4HNE, and high insulin in both hypoxic and normoxic conditions. Hypoxia increased HIF1a gene expression by approximately 30% (P<0.01). TNFα reduced cell proliferation by 10-20%, and chronic TNFα treatment significantly decreased mature adipocytes due to its cytotoxicity. We assessed the impact of insulin resistance (IR) on metabolic pathways, focusing on genes linked to branched-chain amino acid metabolism, detoxification, and chemotaxis. Notably, ALDH6A1 and MCCC1 genes, related to amino acid metabolism, were significantly affected under hypoxic conditions. TNFα treatment notably influenced MCP-1 and MCP-2 genes linked to chemotaxis, with remarkable increases in MCP-1 levels and MCP-2 expression primarily under hypoxia. Detoxification-related genes showed minimal impact, except for a significant increase in MAOA expression under acute hypoxic conditions with TNFα treatment. Additional genes displayed varying effects, warranting further investigation. To investigate insulin signaling's influence in vitro by IRinducing factors, we assessed phospho-protein levels. Our results reveal a significant p-Akt induction with chronic high insulin (10%) and acute TNFα (12%) treatment under hypoxia (both P<0.05). Other insulin resistance-related phospho-proteins (GSK3B, mTOR, PTEN) increased with IL-6, 4HNE, TNFα, and high insulin under hypoxia, while p-IRS1 levels remained unaffected.

Conclusion: In summary, different in vitro models using inflammatory, oxidative stress, and high insulin conditions under hypoxic conditions can capture various aspects of in vivo adipose tissue insulin resistance (IR). Among these models, acute TNFα treatment may offer the most robust approach for inducing IR in 3T3-L1 cells.

Keywords: Insulin resistance, in vitro, hypoxia, methods, adipogenesis, differentiation, factors.

[1]
Blüher M. Metabolically healthy obesity. Endocr Rev 2020; 41(3): bnaa004.
[http://dx.doi.org/10.1210/endrev/bnaa004] [PMID: 32128581]
[2]
Scully T, Ettela A, LeRoith D, Gallagher EJ. Obesity, type 2 diabetes, and cancer risk. Front Oncol 2021; 10: 615375.
[http://dx.doi.org/10.3389/fonc.2020.615375] [PMID: 33604295]
[3]
Zatterale F, Longo M, Naderi J, et al. Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes. Front Physiol 2020; 10: 1607.
[http://dx.doi.org/10.3389/fphys.2019.01607] [PMID: 32063863]
[4]
Campbell JE, Newgard CB. Mechanisms controlling pancreatic islet cell function in insulin secretion. Nat Rev Mol Cell Biol 2021; 22(2): 142-58.
[http://dx.doi.org/10.1038/s41580-020-00317-7] [PMID: 33398164]
[5]
Khalid M, Alkaabi J, Khan MAB, Adem A. Insulin signal transduction perturbations in insulin resistance. Int J Mol Sci 2021; 22(16): 8590.
[http://dx.doi.org/10.3390/ijms22168590] [PMID: 34445300]
[6]
Imierska M, Kurianiuk A, Błachnio-Zabielska A. The influence of physical activity on the bioactive lipids metabolism in obesity-induced muscle insulin resistance. Biomolecules 2020; 10(12): 1665.
[http://dx.doi.org/10.3390/biom10121665] [PMID: 33322719]
[7]
Ertunc ME, Hotamisligil GS. Lipid signaling and lipotoxicity in metaflammation: Indications for metabolic disease pathogenesis and treatment. J Lipid Res 2016; 57(12): 2099-114.
[http://dx.doi.org/10.1194/jlr.R066514] [PMID: 27330055]
[8]
Yaribeygi H, Atkin SL, Simental-Mendía LE, Sahebkar A. Molecular mechanisms by which aerobic exercise induces insulin sensitivity. J Cell Physiol 2019; 234(8): 12385-92.
[http://dx.doi.org/10.1002/jcp.28066] [PMID: 30605232]
[9]
Lo KA, Labadorf A, Kennedy NJ, et al. Analysis of in vitro insulin-resistance models and their physiological relevance to in vivo diet-induced adipose insulin resistance. Cell Rep 2013; 5(1): 259-70.
[http://dx.doi.org/10.1016/j.celrep.2013.08.039] [PMID: 24095730]
[10]
Zhao J, Turpin-Nolan S, Febbraio MA. IL-6 family cytokines as potential therapeutic strategies to treat metabolic diseases. Cytokine 2021; 144: 155549.
[http://dx.doi.org/10.1016/j.cyto.2021.155549] [PMID: 33962843]
[11]
Lobo V, Patil A, Phatak A, Chandra N. Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn Rev 2010; 4(8): 118-26.
[http://dx.doi.org/10.4103/0973-7847.70902] [PMID: 22228951]
[12]
Ma M, Quan Y, Li Y, et al. Bidirectional modulation of insulin action by reactive oxygen species in 3T3‑L1 adipocytes. Mol Med Rep 2018; 18(1): 807-14.
[http://dx.doi.org/10.3892/mmr.2018.9016] [PMID: 29767231]
[13]
Dufau J, Shen JX, Couchet M, et al. In vitro and ex vivo models of adipocytes. Am J Physiol Cell Physiol 2021; 320(5): C822-41.
[http://dx.doi.org/10.1152/ajpcell.00519.2020] [PMID: 33439778]
[14]
Ruiz-Ojeda F, Rupérez A, Gomez-Llorente C, Gil A, Aguilera C. Cell models and their application for studying adipogenic differentiation in relation to obesity: A review. Int J Mol Sci 2016; 17(7): 1040.
[http://dx.doi.org/10.3390/ijms17071040] [PMID: 27376273]
[15]
Kayser B, Verges S. Hypoxia, energy balance, and obesity: An update. Obes Rev 2021; 22(S2) (Suppl. 2): e13192.
[http://dx.doi.org/10.1111/obr.13192] [PMID: 33470528]
[16]
Kolb H. Obese visceral fat tissue inflammation: From protective to detrimental? BMC Med 2022; 20(1): 494.
[http://dx.doi.org/10.1186/s12916-022-02672-y] [PMID: 36575472]
[17]
Akash MSH, Rehman K, Liaqat A. Tumor necrosis factor‐alpha: Role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus. J Cell Biochem 2018; 119(1): 105-10.
[http://dx.doi.org/10.1002/jcb.26174] [PMID: 28569437]
[18]
Regazzetti C, Peraldi P, Grémeaux T, et al. Hypoxia decreases insulin signaling pathways in adipocytes. Diabetes 2009; 58(1): 95-103.
[http://dx.doi.org/10.2337/db08-0457] [PMID: 18984735]
[19]
Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-α, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 2003; 278(46): 45777-84.
[http://dx.doi.org/10.1074/jbc.M301977200] [PMID: 12952969]
[20]
Jaganjac M, Milkovic L, Gegotek A, et al. The relevance of pathophysiological alterations in redox signaling of 4-hydroxynonenal for pharmacological therapies of major stress-associated diseases. Free Radic Biol Med 2020; 157: 128-53.
[http://dx.doi.org/10.1016/j.freeradbiomed.2019.11.023] [PMID: 31756524]
[21]
Guo L, Zhang XM, Zhang YB, Huang X, Chi MH. Association of 4-hydroxynonenal with classical adipokines and insulin resistance in a Chinese non-diabetic obese population. Nutr Hosp 2017; 34(2): 363-8.
[http://dx.doi.org/10.20960/nh.212] [PMID: 28421791]
[22]
Al-Jaber H, Mohamed NA, Govindharajan VK, et al. In vitro and in vivo validation of GATA-3 suppression for induction of adipogenesis and improving insulin sensitivity. Int J Mol Sci 2022; 23(19): 11142.
[http://dx.doi.org/10.3390/ijms231911142] [PMID: 36232443]
[23]
Su L-J, Zhang J-H, Gomez H, Murugan R, Hong X, Xu D. Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and ferroptosis. Oxid Med Cell Longev 2019; 2019
[http://dx.doi.org/10.1155/2019/5080843]
[24]
Murphy MP, Bayir H, Belousov V, et al. Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivo. Nat Metab 2022; 4(6): 651-62.
[http://dx.doi.org/10.1038/s42255-022-00591-z] [PMID: 35760871]
[25]
Korac B, Kalezic A, Pekovic-Vaughan V, Korac A, Jankovic A. Redox changes in obesity, metabolic syndrome, and diabetes. Redox Biol 2021; 42: 101887.
[http://dx.doi.org/10.1016/j.redox.2021.101887] [PMID: 33579666]
[26]
Milkovic L, Zarkovic N, Marusic Z, Zarkovic K, Jaganjac M. The 4-hydroxynonenal–protein adducts and their biological relevance: Are some proteins preferred targets? Antioxidants 2023; 12(4): 856.
[http://dx.doi.org/10.3390/antiox12040856] [PMID: 37107229]
[27]
Rahman MS, Hossain KS, Das S, et al. Role of insulin in health and disease: An update. Int J Mol Sci 2021; 22(12): 6403.
[http://dx.doi.org/10.3390/ijms22126403] [PMID: 34203830]
[28]
van Loo G, Bertrand MJM. Death by TNF: A road to inflammation. Nat Rev Immunol 2023; 23(5): 289-303.
[http://dx.doi.org/10.1038/s41577-022-00792-3] [PMID: 36380021]
[29]
Yeung MC, Lau AS. Mechanism of tumor necrosis factor(TNF)-induced cytotoxicity: Apoptosis, oncogene, and interferon signaling • 934. Pediatr Res 1998; 43(4): 161.
[http://dx.doi.org/10.1203/00006450-199804001-00955]
[30]
Zhang HH, Kumar S, Barnett AH, Eggo MC. Dexamethasone inhibits tumor necrosis factor-α-induced apoptosis and interleukin-1 β release in human subcutaneous adipocytes and preadipocytes. J Clin Endocrinol Metab 2001; 86(6): 2817-25.
[http://dx.doi.org/10.1210/jc.86.6.2817] [PMID: 11397893]
[31]
Warne J. New perspectives on endocrine signalling: Tumor necrosis factor α: A key regulator of adipose tissue mass. J Endocrinol 2003; 2003(177): 351-5.
[http://dx.doi.org/10.1677/joe.0.1770351] [PMID: 12773114]
[32]
Kolaczynski JW, Nyce MR, Considine RV, et al. Acute and chronic effect of insulin on leptin production in humans. Diabetes 1996; 45(5): 699-701.
[http://dx.doi.org/10.2337/diab.45.5.699] [PMID: 8621027]
[33]
Stenkula KG, Erlanson-Albertsson C. Adipose cell size: Importance in health and disease. Am J Physiol Regul Integr Comp Physiol 2018; 315(2): R284-95.
[http://dx.doi.org/10.1152/ajpregu.00257.2017] [PMID: 29641234]
[34]
Sakai T, Sakaue H, Nakamura T, et al. Skp2 controls adipocyte proliferation during the development of obesity. J Biol Chem 2007; 282(3): 2038-46.
[http://dx.doi.org/10.1074/jbc.M608144200] [PMID: 17082193]
[35]
Muir LA, Neeley CK, Meyer KA, et al. Adipose tissue fibrosis, hypertrophy, and hyperplasia: Correlations with diabetes in human obesity. Obesity (Silver Spring) 2016; 24(3): 597-605.
[http://dx.doi.org/10.1002/oby.21377] [PMID: 26916240]
[36]
Cheatham B, Kahn CR. Insulin action and the insulin signaling network. Endocr Rev 1995; 16(2): 117-42.
[PMID: 7781591]
[37]
Suryawan A, Swanson LV, Hu CY. Insulin and hydrocortisone, but not triiodothyronine, are required for the differentiation of pig preadipocytes in primary culture. J Anim Sci 1997; 75(1): 105-11.
[http://dx.doi.org/10.2527/1997.751105x] [PMID: 9027554]
[38]
Palacios-Ortega S, Varela-Guruceaga M, Algarabel M, Milagro FI, Martínez JA, de Miguel C. Effect of TNF-alpha on caveolin-1 expression and insulin signaling during adipocyte differentiation and in mature adipocytes. Cell Physiol Biochem 2015; 36(4): 1499-516.
[http://dx.doi.org/10.1159/000430314] [PMID: 26159107]
[39]
Park YS, Huang Y, Park YJ, et al. Specific down regulation of 3T3-L1 adipocyte differentiation by cell-permeable antisense HIF1α-oligonucleotide. J Control Release 2010; 144(1): 82-90.
[http://dx.doi.org/10.1016/j.jconrel.2010.01.026] [PMID: 20109509]
[40]
Sahai A, Patel MS, Zavosh AS, Tannen RL. Chronic hypoxia impairs the differentiation of 3T3‐L1 fibroblast in culture: Role of sustained protein kinase C activation. J Cell Physiol 1994; 160(1): 107-12.
[http://dx.doi.org/10.1002/jcp.1041600113] [PMID: 8021290]
[41]
Lynch CJ, Adams SH. Branched-chain amino acids in metabolic signalling and insulin resistance. Nat Rev Endocrinol 2014; 10(12): 723-36.
[http://dx.doi.org/10.1038/nrendo.2014.171] [PMID: 25287287]
[42]
Borbás T, Benkő B, Dalmadi B, Szabó I, Tihanyi K. Insulin in flavin-containing monooxygenase regulation. Eur J Pharm Sci 2006; 28(1-2): 51-8.
[http://dx.doi.org/10.1016/j.ejps.2005.12.011] [PMID: 16488120]
[43]
Kleinridders A, Pothos EN. Impact of brain insulin signaling on dopamine function, food intake, reward, and emotional behavior. Curr Nutr Rep 2019; 8(2): 83-91.
[http://dx.doi.org/10.1007/s13668-019-0276-z] [PMID: 31001792]
[44]
Armoni M, Harel C, Zong H, Pessin JE, Karnieli E, Eds. Cyp2E1 role in insulin resistance and weight control: From GLUT4 to energy expenditure. DIABETES. Alexandria, VA 22311-1717 USA.: Amer diabetes assoc 1701 n beauregard st 2011.
[45]
Tazzari PL, Cappellini A, Ricci F, et al. Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts. Leukemia 2007; 21(3): 427-38.
[http://dx.doi.org/10.1038/sj.leu.2404523] [PMID: 17215852]
[46]
Liskova A, Samec M, Koklesova L, et al. Flavonoids as an effective sensitizer for anti-cancer therapy: Insights into multi-faceted mechanisms and applicability towards individualized patient profiles. EPMA J 2021; 12(2): 155-76.
[http://dx.doi.org/10.1007/s13167-021-00242-5] [PMID: 34025826]
[47]
Shimobayashi M, Albert V, Woelnerhanssen B, et al. Insulin resistance causes inflammation in adipose tissue. J Clin Invest 2018; 128(4): 1538-50.
[http://dx.doi.org/10.1172/JCI96139] [PMID: 29528335]
[48]
Feng J, Lu S, Ou B, et al. The role of JNk signaling pathway in obesity-driven insulin resistance. Diabetes Metab Syndr Obes 2020; 13: 1399-406.
[http://dx.doi.org/10.2147/DMSO.S236127] [PMID: 32425571]
[49]
Liu Y, Dhall S, Castro A, Chan A, Alamat R, Martins-Green M. Insulin regulates multiple signaling pathways leading to monocyte/macrophage chemotaxis into the wound tissue. Biol Open 2018; 7(1): bio026187.
[PMID: 29101099]
[50]
Zakaria NF, Hamid M, Khayat ME. Amino acid-induced impairment of insulin signaling and involvement of G-protein coupling receptor. Nutrients 2021; 13(7): 2229.
[http://dx.doi.org/10.3390/nu13072229] [PMID: 34209599]
[51]
Newgard CB, An J, Bain JR, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 2009; 9(4): 311-26.
[http://dx.doi.org/10.1016/j.cmet.2009.02.002] [PMID: 19356713]
[52]
Mugabo Y, Zhao S, Lamontagne J, et al. Metabolic fate of glucose and candidate signaling and excess-fuel detoxification pathways in pancreatic β-cells. J Biol Chem 2017; 292(18): 7407-22.
[http://dx.doi.org/10.1074/jbc.M116.763060] [PMID: 28280244]
[53]
Umbarkar P, Singh S, Arkat S, Bodhankar SL, Lohidasan S, Sitasawad SL. Monoamine oxidase-A is an important source of oxidative stress and promotes cardiac dysfunction, apoptosis, and fibrosis in diabetic cardiomyopathy. Free Radic Biol Med 2015; 87: 263-73.
[http://dx.doi.org/10.1016/j.freeradbiomed.2015.06.025] [PMID: 26122707]
[54]
Emory H, Mizrahi N. Monoamine oxidase inhibition in a patient with type 1 diabetes and depression. J Diabetes Sci Technol 2016; 10(5): 1203-4.
[http://dx.doi.org/10.1177/1932296816638106] [PMID: 26961977]
[55]
Cawthorn WP, Sethi JK. TNF‐α and adipocyte biology. FEBS Lett 2008; 582(1): 117-31.
[http://dx.doi.org/10.1016/j.febslet.2007.11.051] [PMID: 18037376]
[56]
Nong X, Zhang C, Wang J, Ding P, Ji G, Wu T. The mechanism of branched-chain amino acid transferases in different diseases: Research progress and future prospects. Front Oncol 2022; 12: 988290.
[http://dx.doi.org/10.3389/fonc.2022.988290] [PMID: 36119495]
[57]
Yoon MS. The emerging role of branched-chain amino acids in insulin resistance and metabolism. Nutrients 2016; 8(7): 405.
[http://dx.doi.org/10.3390/nu8070405] [PMID: 27376324]
[58]
Quezada C, Alarcón S, Cárcamo JG, Yáñez A, Casanello P, Sobrevia L. Increased expression of the multidrug resistance-associated protein 1 (MRP1) in kidney glomeruli of streptozotocin-induced diabetic rats. Biol Chem 2011; 392(6): 329-37.
[59]
Lee GH, Oh KJ, Kim HR, et al. Effect of BI-1 on insulin resistance through regulation of CYP2E1. Sci Rep 2016; 6(1): 32229.
[http://dx.doi.org/10.1038/srep32229] [PMID: 27576594]
[60]
Rull A, Camps J, Alonso-Villaverde C, Joven J. Insulin resistance, inflammation, and obesity: Role of monocyte chemoattractant protein-1 (orCCL2) in the regulation of metabolism. Mediators Inflamm 2010; 2010
[61]
Torrente Y, Fahime EE, Caron NJ, et al. Tumor necrosis factor-α (TNF-α) stimulates chemotactic response in mouse myogenic cells. Cell Transplant 2003; 12(1): 91-100.
[http://dx.doi.org/10.3727/000000003783985115] [PMID: 12693669]
[62]
Liu HY, Hong T, Wen GB, et al. Increased basal level of Akt-dependent insulin signaling may be responsible for the development of insulin resistance. Am J Physiol Endocrinol Metab 2009; 297(4): E898-906.
[http://dx.doi.org/10.1152/ajpendo.00374.2009] [PMID: 19638508]
[63]
Zhang Z, Liu H, Liu J. Akt activation: A potential strategy to ameliorate insulin resistance. Diabetes Res Clin Pract 2019; 156: 107092.
[http://dx.doi.org/10.1016/j.diabres.2017.10.004] [PMID: 29111280]
[64]
Ong PS, Wang LZ, Dai X, Tseng SH, Loo SJ, Sethi G. Judicious toggling of mTOR activity to combat insulin resistance and cancer: Current evidence and perspectives. Front Pharmacol 2016; 7: 395.
[http://dx.doi.org/10.3389/fphar.2016.00395] [PMID: 27826244]
[65]
da Costa RM, Neves KB, Mestriner FL, Louzada-Junior P, Bruder-Nascimento T, Tostes RC. TNF-α induces vascular insulin resistance via positive modulation of PTEN and decreased Akt/eNOS/NO signaling in high fat diet-fed mice. Cardiovasc Diabetol 2016; 15(1): 119.
[http://dx.doi.org/10.1186/s12933-016-0443-0] [PMID: 27562094]
[66]
Xue B, Rim JS, Hogan JC, Coulter AA, Koza RA, Kozak LP. Genetic variability affects the development of brown adipocytes in white fat but not in interscapular brown fat. J Lipid Res 2007; 48(1): 41-51.
[http://dx.doi.org/10.1194/jlr.M600287-JLR200] [PMID: 17041251]
[67]
Dilworth L, Facey A, Omoruyi F. Diabetes mellitus and its metabolic complications: The role of adipose tissues. Int J Mol Sci 2021; 22(14): 7644.
[http://dx.doi.org/10.3390/ijms22147644] [PMID: 34299261]
[68]
Sethi JK, Hotamisligil GS. Metabolic Messengers: Tumour necrosis factor. Nat Metab 2021; 3(10): 1302-12.
[http://dx.doi.org/10.1038/s42255-021-00470-z] [PMID: 34650277]
[69]
Pekala P, Kawakami M, Vine W, Lane MD, Cerami A. Studies of insulin resistance in adipocytes induced by macrophage mediator. J Exp Med 1983; 157(4): 1360-5.
[http://dx.doi.org/10.1084/jem.157.4.1360] [PMID: 6833952]
[70]
Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 1993; 259(5091): 87-91.
[http://dx.doi.org/10.1126/science.7678183] [PMID: 7678183]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy